Displaying One Session

Leon Auditorium (Hall 3) Patient Advocacy session
Date
27.09.2019
Time
16:00 - 17:30
Location
Leon Auditorium (Hall 3)
Chairs
  • Ananda Plate (Charleroi, Belgium)
  • Bettina Ryll (Uppsala, Sweden)
Drugs in combination Patient Advocacy session

Welcome and introduction (ID 949)

Lecture Time
16:00 - 16:10
Speakers
  • Bettina Ryll (Uppsala, Sweden)
Session Name
Location
Leon Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
27.09.2019
Time
16:00 - 17:30
Drugs in combination Patient Advocacy session

When it takes more than one drug to survive: The myeloma experience (ID 948)

Lecture Time
16:10 - 16:25
Speakers
  • Katheryn Elun Morgan (Brussels, Belgium)
Session Name
Location
Leon Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
27.09.2019
Time
16:00 - 17:30
Drugs in combination Patient Advocacy session

How to evaluate drugs in combination: A regulatory perspective (ID 7274)

Lecture Time
16:25 - 16:40
Speakers
  • Francesco Pignatti (London, United Kingdom)
Session Name
Location
Leon Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
27.09.2019
Time
16:00 - 17:30
Drugs in combination Patient Advocacy session

Establishing cost-effectiveness in combinations (ID 950)

Lecture Time
16:40 - 16:55
Speakers
  • Carla Deakin (London, United Kingdom)
Session Name
Location
Leon Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
27.09.2019
Time
16:00 - 17:30
Drugs in combination Patient Advocacy session

And who is going to pay for it all? A payer’s perspective (ID 951)

Lecture Time
16:55 - 17:10
Speakers
  • Linda Van Saase (Diemen, Netherlands)
Session Name
Location
Leon Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
27.09.2019
Time
16:00 - 17:30
Drugs in combination Patient Advocacy session

Conclusion (ID 953)

Lecture Time
17:10 - 17:30
Speakers
  • Bettina Ryll (Uppsala, Sweden)
Session Name
Location
Leon Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
27.09.2019
Time
16:00 - 17:30